Fig. 2.1 Dissemination tumor process. Metastasis process involves the relapse of tumor cells from primary tumor to target organ. This metastasis process is dependent to survival capacity of different subpopulation…
Fig. 16.1 Schematic diagrams of Bioresonance therapy Bioresonance therapy (BRT) is based upon the knowledge that the entire body is held together at the subatomic level by waves and photons….
Fig. 5.1 TGF-β signaling prevents cancer development, but promote carcinogenesis and angiogenesis in advanced carcinomas. TGF-β regulates immune system by the mediation of FOXP3, which is over-expressed in tumor cells…
Study Number of patients Treatment Assay MGMT status (frequency, %) Survival p PFS OS PFS OS Newly diagnosed glioblastoma Jaeckle et al. 1998 40 SR-RT-BCNU Protein expression: quantative immunofluorescence Low level:…
Study Year Study population Method Main Result 1-(Snell et al. 2008) 2008 Familial breast cancer without BRCA1or BRCA2 mutations MethyLight, MS-HRM (Methylation specific high resolution melting) Hypermethylation of BRCA1 in tumors,…
Species Chromosomal location Gene symbol Size Other symbols Human 3p24.2 RARB 423 kb HAP, RRB2, NR1B2, MCOPS12 Mouse 14 A1-A3; 14 7.08 cM Rarb 164 kb Hap, Nr1b2, RARbeta2, A830025K23…
Fig. 4.1 Gross specimen showing a white pearly irregular tumor with pale yellow gritty areas likely corresponding to comedo necrosis Classic histologic features of DCIS include cohesive, clonal-appearing epithelial cells…
Fig. 3.1 Secretory calcifications present as large rod-like calcifications and are associated with ductal ectasia Fig. 3.2 Milk of calcium is associated with fibrocystic changes. a Cranial caudal view demonstrates…
Variable BRCA1 BRCA2 Surrounding invasive tumor < Sporadic controls = Sporadic controls Presence in prophylactic mastectomy specimens Increased in women more than 40 years of age Increased in women over 40 years…
Fig. 1.1 Age-adjusted Surveillance, Epidemiology, and End Results (SEER) incidence rates by age at diagnosis/death; breast (in situ), female, all races, female 1975–2011 (SEER 9; Cancer sites include invasive cases…
